Research & Development

Can Metallic Nanoparticles Solve the Antibiotic Crisis?
Research & Development Can Metallic Nanoparticles Solve the Antibiotic Crisis?

Small-scale nanoparticles are uniquely capable of penetrating the dense architecture of biofilms to disrupt the quorum sensing communication that bacteria use to maintain their survival. This revelation comes at a time when the global medical community is facing a significant crossroads, as the

Is Cancer Stemness the Key to Prostate Cancer Resistance?
Research & Development Is Cancer Stemness the Key to Prostate Cancer Resistance?

The clinical reality of lineage plasticity allows prostate cancer cells to survive treatment by shedding their identity and adopting forms that do not require androgen. This phenomenon presents a persistent challenge in oncology, as traditional therapies predominantly target the androgen receptor

Can G-Quadruplex Targeting Finally Silencing c-MYC?
Research & Development Can G-Quadruplex Targeting Finally Silencing c-MYC?

Genetic blueprints have long been visualized as sleek, predictable spirals, yet the hidden reality of our DNA involves complex architectural knots that could hold the secret to dismantling the most aggressive forms of human cancer. While the Watson-Crick double helix remains the foundation of

FDA Clears Over 1,500 AI Medical Tools Amid Efficacy Concerns
Research & Development FDA Clears Over 1,500 AI Medical Tools Amid Efficacy Concerns

The medical community stands at a crossroads where the convenience of AI-designed diagnostics must be balanced against the rigorous demands of patient safety and survival statistics. As of the current count in 2026, the US Food and Drug Administration has authorized exactly 1,524 AI-enabled medical

Does the Utah H5N1 Mink Outbreak Pose a New Pandemic Risk?
Research & Development Does the Utah H5N1 Mink Outbreak Pose a New Pandemic Risk?

Virologists are particularly concerned about the role of mink as a biological mixing vessel where different influenza strains can swap genes and adapt to mammals. This concern has taken center stage in 2026 as Utah’s captive mink population faces a significant outbreak of the H5N1 bird flu, marking

What Is the Future of the Cell and Gene Therapy Market?
Research & Development What Is the Future of the Cell and Gene Therapy Market?

Specialized logistics firms like Cryoport Inc. held a 4% market share in 2025, highlighting the critical role of cold chain infrastructure in transporting temperature-sensitive live cell products. This reality emphasizes a profound shift within the pharmaceutical sector, where the focus is

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later